Sleemon Healthy Sleep Technology Co., Ltd. (SHA:603008)
China flag China · Delayed Price · Currency is CNY
8.80
+0.25 (2.92%)
Sep 1, 2026, 3:00 PM CST

SHA:603008 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
8,4408,6488,5948,5797,7417,652
Other Revenue
170.78170.78135.0499.6797.35119.39
8,6108,8198,7298,6787,8397,772
Revenue Growth
-2.07%1.03%0.58%10.71%0.86%38.21%
Cost of Revenue
5,7855,6885,8035,7135,3175,295
Gross Profit
2,8253,1302,9262,9662,5222,477
Selling, General & Admin
2,4082,4352,3232,1711,9191,498
Research & Development
199.96198.97162.16179.85191.49183.22
Other Operating Expenses
63.5465.8348.0351.9958.7452.42
Operating Expenses
2,6892,7172,5552,4542,1871,787
Operating Income
136.57412.92371.77511.71334.4689.37
Interest Expense
-83.11-83.11-78-70.23-89.96-65.99
Interest & Investment Income
31.3731.3729.6943.9336.4274.18
Currency Exchange Gain (Loss)
-6.65-6.6527.6533.7928.91-12.37
Other Non Operating Income (Expenses)
-63.44-6.15-9.17-5.21-6.62-4.81
EBT Excluding Unusual Items
14.74348.38341.94513.98303.16680.39
Impairment of Goodwill
-25.49-25.49----
Gain (Loss) on Sale of Investments
-24.19-14.668.21-1.2-22.361.34
Gain (Loss) on Sale of Assets
0.93-0.010.12-1.45-2.36-4.29
Asset Writedown
-1.42-6.77-23.72-1.34-0
Other Unusual Items
17.1917.1927.8445.4343.8229.8
Pretax Income
-18.23318.64354.4555.41322.26707.25
Income Tax Expense
40.5580.7527.83107.6450.04101.92
Earnings From Continuing Operations
-58.77237.89326.57447.77272.22605.33
Minority Interest in Earnings
-2.513.52-4.21-18.9-34.67-46.58
Net Income
-61.28241.41322.36428.87237.55558.75
Net Income to Common
-61.28241.41322.36428.87237.55558.75
Net Income Growth
--25.11%-24.83%80.54%-57.49%78.29%
Shares Outstanding (Basic)
367371379386383385
Shares Outstanding (Diluted)
367371379386383385
Shares Change
-3.04%-2.07%-1.84%0.84%-0.57%-1.64%
EPS (Basic)
-0.170.650.851.110.621.45
EPS (Diluted)
-0.170.650.851.110.621.45
EPS Growth
--23.53%-23.42%79.03%-57.24%81.25%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
252.01249.91425.19680.4-13.25211.54
Free Cash Flow Per Share
0.690.671.121.76-0.040.55
Dividend Per Share
0.5600.5600.5200.5000.0800.280
Dividend Growth
7.69%7.69%4.00%525.00%-71.43%12.00%
Gross Margin
32.81%35.49%33.53%34.17%32.17%31.87%
Operating Margin
1.59%4.68%4.26%5.90%4.27%8.87%
Profit Margin
-0.71%2.74%3.69%4.94%3.03%7.19%
Free Cash Flow Margin
2.93%2.83%4.87%7.84%-0.17%2.72%
EBITDA
306.64582.17630.65762.74484.45824.98
EBITDA Margin
3.56%6.60%7.22%8.79%6.18%10.62%
D&A For EBITDA
170.07169.24258.87251.03150.05135.6
EBIT
136.57412.92371.77511.71334.4689.37
EBIT Margin
1.59%4.68%4.26%5.90%4.27%8.87%
Effective Tax Rate
-25.34%7.85%19.38%15.53%14.41%
Revenue as Reported
8,8198,8198,7298,6787,8397,772